A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients

NCT00201825 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Non-Small-Cell Lung Carcinoma

Interventions

DRUG: Capecitabine
DRUG: Docetaxel

Sponsor

Tony Bekaii-Saab

Collaborators

[object Object]